Industry News

Lynparza Approved in UK as Combination Therapy for Treatment of Metastatic Castration-Resistant Prostate Cancer

March 22, 2023

The decision was based on results from the PROpel Phase III trial.

European Commission Approves Dupixent as First, Only Targeted Medicine for Children with Severe Atopic Dermatitis

March 22, 2023

This approval makes the drug the first and only targeted medicine indicated to treat this population of children in Europe and the United States.

Sanofi Drops Lantus US List Price by 78%, Capping Out-of-Pocket Costs at $35

March 21, 2023

Sanofi intends to cut its US list price for Lantus (insulin glargine injection) by 78% and cap out-of-pocket costs at $35 for all patients with commercial insurance.

EMA Management Board Continues to Monitor Critical Shortages of Medicines

March 21, 2023

Additionally, the MSG discussed plans to mitigate shortages of antibiotics for the next autumn and winter season.

Evotec and Bristol Myers Squibb Progress Strategic Partnership

March 17, 2023

Evotec and Bristol Myers Squibb have announced progress in their strategic protein degradation partnership.

Predictive Oncology and Cancer Research Horizons Partner for Cancer Drug Development

March 17, 2023

Predictive Oncology and Cancer Research Horizons have partnered to pursue development of cancer drugs utilizing the PEDAL platform.

First Drugs Hit by Inflation Reduction Act Price Controls

March 16, 2023

27 drugs within Medicare will face penalties for having their prices raised faster than the rate of inflation.

Acadia Pharmaceuticals Receives FDA Approval for First Treatment for Rare Genetic Disorder

March 14, 2023

FDA has approved Acadia Pharmaceuticlas’ Daybue (trofinetide), the first treatment for Rett syndrome, a rare genetic disorder.

FDA Approves Pfizer’s New Migraine Nasal Spray

March 14, 2023

FDA has approved Pfizer’s ZAVZPRET (zavegepant), a new nasal spray treatment for migraine.

FDA Seeks $7.2 Billion to Protect and Advance Public Health

March 14, 2023

FDA is seeking $7.2 billion to enhance food safety and advance medical product availability.